Ausgabe 5/2016
Inhalt (25 Artikel)
Excretion of radionuclides in human breast milk after nuclear medicine examinations. Biokinetic and dosimetric data and recommendations on breastfeeding interruption
Sigrid Leide-Svegborn, Lars Ahlgren, Lennart Johansson, Sören Mattsson
Commentary on: “Occupational radiation exposure of medical staff performing 90Y-loaded microsphere radioembolization”
Vanessa L. Gates, Ahmed Gabr, Joseph Kallini, Robert J. Lewandowski, Riad Salem
Occupational radiation exposure of medical staff performing 90Y-loaded microsphere radioembolization
Sophie Laffont, Yan Rolland, Valérie Ardisson, Julien Edeline, Marc Pracht, Samuel Le Sourd, Tanguy Rohou, Laurence Lenoir, Nicolas Lepareur, Etienne Garin
FDG uptake at the bronchial stump after curative lobectomy for non-small cell lung cancer
Caroline Keyzer, Florence Corbusier, Eirini Kyratzi, Youri Sokolow, Pierre Alain Gevenois, Serge Goldman
Measurement of circulating transcripts and gene cluster analysis predicts and defines therapeutic efficacy of peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors
L. Bodei, M. Kidd, I. M. Modlin, S. Severi, I. Drozdov, S. Nicolini, D. J. Kwekkeboom, E. P. Krenning, R. P. Baum, G. Paganelli
Diagnostic value of combining 11C-choline and 18F-FDG PET/CT in hepatocellular carcinoma
Maria-Angéla Castilla-Lièvre, Dominique Franco, Philippe Gervais, Bertrand Kuhnast, Hélène Agostini, Lysiane Marthey, Serge Désarnaud, Badia-Ourkia Helal
Assessing the role of 18F-FDG PET and 18F-FDG PET/CT in the diagnosis of soft tissue musculoskeletal malignancies: a systematic review and meta-analysis
Elba C. Etchebehere, Brian P. Hobbs, Denái R. Milton, Osama Malawi, Shreyaskumar Patel, Robert S. Benjamin, Homer A. Macapinlac
The role of patient-based treatment planning in peptide receptor radionuclide therapy
Deni Hardiansyah, Christian Maass, Ali Asgar Attarwala, Berthold Müller, Peter Kletting, Felix M. Mottaghy, Gerhard Glatting
Diagnostic performance of FDG PET/CT for surveillance in asymptomatic gastric cancer patients after curative surgical resection
Jeong Won Lee, Sang Mi Lee, Myoung Won Son, Moon-Soo Lee
MRI versus 68Ga-PSMA PET/CT for gross tumour volume delineation in radiation treatment planning of primary prostate cancer
Constantinos Zamboglou, Gesche Wieser, Steffen Hennies, Irene Rempel, Simon Kirste, Martin Soschynski, Hans Christian Rischke, Tobias Fechter, Cordula A. Jilg, Mathias Langer, Philipp T. Meyer, Michael Bock, Anca-Ligia Grosu
Biphasic 68Ga-PSMA-HBED-CC-PET/CT in patients with recurrent and high-risk prostate carcinoma
Carsten-Oliver Sahlmann, Birgit Meller, Caroline Bouter, Christian Oliver Ritter, Philipp Ströbel, Joachim Lotz, Lutz Trojan, Johannes Meller, Sameh Hijazi
Molecular imaging of cholinergic processes in prostate cancer using 11C-donepezil and 18F-FEOBV
Morten Gersel Stokholm, Søren Høyer, Michael Borre, Dirk Bender, Steen Jakobsen, Jørgen Frøkiær, Per Borghammer
Impact of consensus contours from multiple PET segmentation methods on the accuracy of functional volume delineation
A. Schaefer, M. Vermandel, C. Baillet, A. S. Dewalle-Vignion, R. Modzelewski, P. Vera, L. Massoptier, C. Parcq, D. Gibon, T. Fechter, U. Nemer, I. Gardin, U. Nestle
Theranostic pretargeted radioimmunotherapy of colorectal cancer xenografts in mice using picomolar affinity 86Y- or 177Lu-DOTA-Bn binding scFv C825/GPA33 IgG bispecific immunoconjugates
Sarah M. Cheal, Hong Xu, Hong-fen Guo, Sang-gyu Lee, Blesida Punzalan, Sandhya Chalasani, Edward K. Fung, Achim Jungbluth, Pat B. Zanzonico, Jorge A. Carrasquillo, Joseph O’Donoghue, Peter M. Smith-Jones, K. Dane Wittrup, Nai-Kong V. Cheung, Steven M. Larson
Cancer theranostics with 64Cu/177Lu-loaded liposomes
Emily B. Ehlerding, Shreya Goel, Weibo Cai
In vivo evaluation of PEGylated 64Cu-liposomes with theranostic and radiotherapeutic potential using micro PET/CT
Anncatrine Luisa Petersen, Jonas Rosager Henriksen, Tina Binderup, Dennis Ringkjøbing Elema, Palle Hedengran Rasmussen, Anne Mette Hag, Andreas Kjær, Thomas Lars Andresen
In vivo biokinetic and metabolic characterization of the 68Ga-labelled α5β1-selective peptidomimetic FR366
Calogero D’Alessandria, Karolin Pohle, Florian Rechenmacher, Stefanie Neubauer, Johannes Notni, Hans-Jürgen Wester, Markus Schwaiger, Horst Kessler, Ambros J. Beer
Preclinical and first clinical experience with the gastrin-releasing peptide receptor-antagonist [68Ga]SB3 and PET/CT
Theodosia Maina, Hendrik Bergsma, Harshad R. Kulkarni, Dirk Mueller, David Charalambidis, Eric P. Krenning, Berthold A. Nock, Marion de Jong, Richard P. Baum
Molecular imaging of EGFR and CD44v6 for prediction and response monitoring of HSP90 inhibition in an in vivo squamous cell carcinoma model
Diana Spiegelberg, Anja C. Mortensen, Ram K. Selvaraju, Olof Eriksson, Bo Stenerlöw, Marika Nestor
18F-FDG PET/CT in the early prediction of pathological response in aggressive subtypes of breast cancer: review of the literature and recommendations for use in clinical trials
David Groheux, David Mankoff, Marc Espié, Elif Hindié
Metabolic-structural concordance in paraneoplastic limbic encephalitis
K. E. Goffin, D. Ooms, R. Ahmad, P. Demaerel, W. Van Paesschen, K. Van Laere, J. Vansteenkiste, C. M. Deroose, O. Gheysens
Richard P. Baum (ed): Therapeutic Nuclear Medicine. Springer Verlag Berlin Heidelberg, 2014, ISBN: 978-3-540-36719-2
Barbara Russo, Luigi Mansi
L. Mansi, E. Lopci, V. Cuccurullo and A. Chiti (eds): Clinical Nuclear Medicine in Pediatrics
Angelika Bischof Delaloye